# Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma

> **NCT01584726** · NA · UNKNOWN · sponsor: **Hamad Medical Corporation** · enrollment: 400 (estimated)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Magnesium Sulfate

## Key facts

- **NCT ID:** NCT01584726
- **Lead sponsor:** Hamad Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-12
- **Primary completion:** 2015-03
- **Final completion:** 2015-12
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2014-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01584726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01584726, "Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01584726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*